Rheinmetall: Analyst Conviction Holds as Targets Drop, but Strategic Moves Add Uncertainty

Rheinmetall's solid Q1 beat fails to impress as UBS and Jefferies slash price targets; stock down 24% YTD amid execution fears and strategic expansion.

Rheinmetall delivered a solid first quarter – revenues up, profits climbing – yet the market yawned, and two heavyweight banks responded by slashing their price targets. The disconnect between operational momentum and analyst caution tells a tale of a defence champion caught between near-term execution fears and long-term structural shifts.

Q1 Numbers Beat, But Not Enough

For the period ending March 2026, the German defence contractor posted revenue of €1.94 billion, a 7.7% gain year-on-year. Operating profit rose 17% to €224 million. By any normal measure, a strong quarter. But expectations had been set higher by a market accustomed to explosive growth. The mild disappointment triggered a swift recalibration among analysts.

UBS was the most aggressive. Analyst Sven Weier cut the target from €2,200 to €1,600 – a 27% reduction and a €600 slash. His thesis: long-term defence budgets may tilt toward new technologies, leaving Rheinmetall’s traditional strength in land vehicles exposed. Yet he kept a “Buy” rating, arguing the market underestimates growth in the munitions division and the success of the Boxer armoured vehicle.

Jefferies followed suit. Chloe Lemarie lowered the target to €1,890 from €2,220, citing elevated execution risks. She pushed back against concerns that land defence systems are losing relevance, calling them “exaggerated.” Jefferies also stuck with a “Buy” call.

Barclays proved the lone holdout. It reaffirmed its €2,035 target and “Overweight” rating, forecasting a 45% surge in 2026 operating profit – well above the sector average of roughly 19%. For Barclays, the real test comes in the second quarter, when operational delivery will either validate or undermine the bullish thesis.

The Price Pain in Context

Rheinmetall shares closed Friday at €1,221.60 – roughly 39% below their 52-week high of €1,995. The year-to-date decline stands at 24%, and over the trailing twelve months the stock has shed more than 31%. A modest Friday gain of 0.46% capped a week that still saw a 9% advance, with the 52-week low of €1,118 – set on 13 May – now about 9% below the current price.

Despite the slide, all three bank targets sit comfortably above the market, underscoring a consensus that the equity is undervalued – but also highlighting how far it has drifted from former heights.

Strategic Chess Moves on the Board

While analysts sharpen their models, management appears to be playing a longer game. Rheinmetall is reportedly eyeing the military division of Italian truck maker Iveco, whose Agnelli family is in talks over a partial sale. A deal would strengthen the group’s European land defence footprint – and with an order backlog of €73 billion at the end of Q1, the financial firepower is there.

Less comfortable is the legal shadow over German procurement. The Higher Regional Court in Düsseldorf has ruled parts of the Bundeswehr acceleration law unconstitutional, kicking the final decision to the Federal Constitutional Court. Depending on the outcome, planning certainty for large-scale projects could take a hit – a risk that analysts are likely factoring into their cautious near-term outlook.

Catalysts on the Horizon

Next week’s Barclays conference features a scheduled management meeting, offering investors a chance to probe concerns over product relevance and margin trends directly. Strong order inflows earlier in the year are seen as the most potent tool to rebuild confidence; fresh large-scale contracts could dramatically narrow the gap between the current share price and the optimistic bank targets.

The next quarterly report is due on 6 August 2026. Until then, the share price will probably be driven by news flow from European defence initiatives – and by whether management can translate its €73 billion order book into visible earnings momentum. The bull case remains intact for now, but execution, not aspiration, will determine whether the stock can claw its way back toward the levels the banks still believe it deserves.